Positron emission tomography (PET) uses radioactive tracers and enables the functional
imaging of several metabolic processes, blood flow measurements, regional chemical …

Positron emission tomography with selective radioligands advances the drug discovery and
development process by revealing information about target engagement, proof of …

Positron emission tomography (PET) is an extensively used nuclear functional imaging
technique, especially for central nervous system (CNS) and oncological disorders. Currently …

Positron emission tomography (PET)/computed tomography (CT) is a rapidly expanding
imaging modality, thanks to the availability of compact medical cyclotrons and automated …

Molecular imaging is an emerging technology that allows the visualization of interactions
between molecular probes and biological targets. Molecules that either direct or are subject …

Positron Emission Tomography (PET) is a sophisticated nuclear imaging modality that
affords researchers the ability to conduct both functional and molecular imaging on …

Positron Emission Tomography (PET) is a diagnostic imaging procedure used regularly to
acquire essential clinical information. The PET-CT hybrid, which consists of two scanning …

The positron emission tomography (PET) molecular imaging technique has gained its
universal value as a remarkable tool for medical diagnosis and biomedical research …

The presented review provides general background on PET radiopharmaceuticals for
oncological applications. Special emphasis is put on radiopharmacological, radiochemical …

While the development of positron emission tomography (PET) radiopharmaceuticals
closely follows that of traditional drug development, there are several key considerations in …